BACKGROUND: When patients visit a community pharmacy for the first time, the creation of an electronic patient record (EPR) with relevant and up-to-date data is a prerequisite for adequate medication surveillance and patient counseling. OBJECTIVE: To investigate the level of completeness of documentation in the EPR after a patient's first visit to a Dutch community pharmacy. METHODS: In each participating pharmacy, newly enlisted (<3 mo) patients to whom at least one medication had been dispensed were enrolled in this survey. For each patient who could be interviewed, pharmacy master students used a structured questionnaire to gather relevant, mandatory patient data (ie, basic characteristics, current drugs used, diseases, intolerabilities, specific conditions) and nonmandatory patient data (eg, diagnostic and monitoring data, personal experiences and habits, drug use problems) from the patient's EPR and from a structured telephone interview with the patient. Data retrieved from the patient's EPR were compared with data provided by the patient during the telephone interview. RESULTS: Of 403 selected patients, 154 (38.2%) could be interviewed by telephone. Poor documentation of telephone numbers in the EPR was the main reason for nonresponse (134/249). Interviewers found that 67.7% of prescription drugs, 0% of over-the-counter drugs, 19.6% of diseases, 3.7% of intolerabilities, and none of the specific conditions reported by patients had been documented in the EPR. Nonmandatory data (personal experiences and habits, drug use problems) reported during the patient interview had not been documented in the EPR. CONCLUSIONS: The EPR after a patient's first visit to the community pharmacy is often incomplete. For new patients, the pharmacist should more proactively and systematically gather patient information, and all relevant information should be recorded, preferably in coded form, in the pharmacy information system to allow more adequate clinical risk management.
BACKGROUND: When patients visit a community pharmacy for the first time, the creation of an electronic patient record (EPR) with relevant and up-to-date data is a prerequisite for adequate medication surveillance and patient counseling. OBJECTIVE: To investigate the level of completeness of documentation in the EPR after a patient's first visit to a Dutch community pharmacy. METHODS: In each participating pharmacy, newly enlisted (<3 mo) patients to whom at least one medication had been dispensed were enrolled in this survey. For each patient who could be interviewed, pharmacy master students used a structured questionnaire to gather relevant, mandatory patient data (ie, basic characteristics, current drugs used, diseases, intolerabilities, specific conditions) and nonmandatory patient data (eg, diagnostic and monitoring data, personal experiences and habits, drug use problems) from the patient's EPR and from a structured telephone interview with the patient. Data retrieved from the patient's EPR were compared with data provided by the patient during the telephone interview. RESULTS: Of 403 selected patients, 154 (38.2%) could be interviewed by telephone. Poor documentation of telephone numbers in the EPR was the main reason for nonresponse (134/249). Interviewers found that 67.7% of prescription drugs, 0% of over-the-counter drugs, 19.6% of diseases, 3.7% of intolerabilities, and none of the specific conditions reported by patients had been documented in the EPR. Nonmandatory data (personal experiences and habits, drug use problems) reported during the patient interview had not been documented in the EPR. CONCLUSIONS: The EPR after a patient's first visit to the community pharmacy is often incomplete. For new patients, the pharmacist should more proactively and systematically gather patient information, and all relevant information should be recorded, preferably in coded form, in the pharmacy information system to allow more adequate clinical risk management.
Authors: Fatma Karapinar-Çarkıt; Ben R L van Breukelen; Sander D Borgsteede; Marjo J A Janssen; Antoine C G Egberts; Patricia M L A van den Bemt Journal: Int J Clin Pharm Date: 2014-06-11
Authors: Marnix P D Westein; Harry de Vries; Annemieke Floor; Andries S Koster; Henk Buurma Journal: Am J Pharm Educ Date: 2019-08 Impact factor: 2.047
Authors: Anne J Leendertse; Fred H P de Koning; Alex N Goudswaard; Andries R Jonkhoff; Sander C A van den Bogert; Han J de Gier; Toine C G Egberts; Patricia M L A van den Bemt Journal: BMC Health Serv Res Date: 2011-01-07 Impact factor: 2.655
Authors: S Elina Aaltonen; Niina P Laine; Daisy Volmer; Manjiri S Gharat; Ruta Muceniece; Anna Vitola; Veerle Foulon; Franciska A Desplenter; Marja S Airaksinen; Timothy F Chen; J Simon Bell Journal: Pharm Pract (Granada) Date: 2010-03-15